BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17804498)

  • 1. Interaction of decay-accelerating factor with coxsackievirus B3.
    Hafenstein S; Bowman VD; Chipman PR; Bator Kelly CM; Lin F; Medof ME; Rossmann MG
    J Virol; 2007 Dec; 81(23):12927-35. PubMed ID: 17804498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.
    He Y; Lin F; Chipman PR; Bator CM; Baker TS; Shoham M; Kuhn RJ; Medof ME; Rossmann MG
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10325-9. PubMed ID: 12119400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.
    Yoder JD; Cifuente JO; Pan J; Bergelson JM; Hafenstein S
    J Virol; 2012 Dec; 86(23):12571-81. PubMed ID: 22973031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
    Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
    J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of decay-accelerating factor with echovirus 7.
    Plevka P; Hafenstein S; Harris KG; Cifuente JO; Zhang Y; Bowman VD; Chipman PR; Bator CM; Lin F; Medof ME; Rossmann MG
    J Virol; 2010 Dec; 84(24):12665-74. PubMed ID: 20881044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.
    Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM
    J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.
    He Y; Chipman PR; Howitt J; Bator CM; Whitt MA; Baker TS; Kuhn RJ; Anderson CW; Freimuth P; Rossmann MG
    Nat Struct Biol; 2001 Oct; 8(10):874-8. PubMed ID: 11573093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
    Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
    J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
    Shafren DR; Williams DT; Barry RD
    J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
    Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
    Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
    Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
    J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of differential receptor usage for naturally occurring CD55-binding and -nonbinding coxsackievirus B3 strains.
    Wang Q; Yang Q; Liu C; Wang G; Song H; Shang G; Peng R; Qu X; Liu S; Cui Y; Wang P; Xu W; Zhao X; Qi J; Yang M; Gao GF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.
    Powell RM; Schmitt V; Ward T; Goodfellow I; Evans DJ; Almond JW
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1707-13. PubMed ID: 9680134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.
    Spiller OB; Goodfellow IG; Evans DJ; Almond JW; Morgan BP
    J Infect Dis; 2000 Jan; 181(1):340-3. PubMed ID: 10608785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.
    Carson SD; Chapman NM; Hafenstein S; Tracy S
    J Virol; 2011 Apr; 85(7):3306-14. PubMed ID: 21270163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.
    Rezaikin AV; Novoselov AV; Sergeev AG; Fadeyev FA; Lebedev SV
    Virus Res; 2009 Oct; 145(1):74-9. PubMed ID: 19540285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
    Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
    Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
    Huber S; Song WC; Sartini D
    Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
    Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.
    Pettigrew DM; Williams DT; Kerrigan D; Evans DJ; Lea SM; Bhella D
    J Biol Chem; 2006 Feb; 281(8):5169-77. PubMed ID: 16272562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.